On August 3, 2022 Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, reported that it will provide business updates and report financial results for the second quarter ended June 30, 2022 on Monday, August 8, 2022 and will host a conference call and webcast at 4:30 p.m. Eastern Time that afternoon (Press release, Mersana Therapeutics, AUG 3, 2022, View Source [SID1234617337]). Members of management will also be presenting at two upcoming conferences. Details are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Mersana Second Quarter 2022 Conference Call
Format: Webcast and Call
Date/Time: Monday, August 8, 2022, at 4:30 p.m. Eastern Time
2022 Wedbush PacGrow Healthcare Virtual Conference
Format: Panel
Panel Name: ADCs – Take Me to Your Tumor
Date/Time: Wednesday, August 10, 2022, at 2:20 p.m. Eastern Time
Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) Webinar
Format: Panel
Panel Name: Targeted Systemic Delivery of Innate Immune Activators: A Deep Dive in Targets for Cancer IO
Date/Time: Friday, August 26, 2022, at 11:00 a.m. Eastern Time
To access Mersana’s second quarter conference call live, please dial 646-307-1963 (domestic) or 800-715-9871 (international) and provide the Conference ID 4656534. Live webcasts of all the presentations above will be accessible via the Investors & Media section of the Mersana website at www.mersana.com, and webcast replays of the second quarter conference call and Wedbush panel will be available in the same location for approximately 90 days following the live events.